RIPK3 and neoplasm: In COAD, RIPK3-mediated inflammation can promote intestinal tumors by inducing an immune-suppressive tumor microenvironment, and RIPK1 has been shown to interact with mitochondrial Ca2+ uniporter to promote colorectal oncogenesis (12, 29).